AnGes Inc Sustainability Reports
AnGes, Inc. focuses on the research, development, and commercialization of gene-based medicines, nucleic acid drugs, and diagnostic testing services for rare diseases.
Sector: Manufacturing
Country: Japan
Exchange: Tokyo Stock Exchange
LEI: 529900HERUBGP6BTMO45
FIGI: BBG001SL2FT3
1 reports from 2025 to 2025